EXCLUSIVE LICENSE and SALES AND LICENSING AGREEMENTS FIRST AMENDMENTRapid Therapeutic Science Laboratories, Inc. • August 27th, 2020 • Pharmaceutical preparations
Company FiledAugust 27th, 2020 IndustryTHIS FIRST AMENDEMENT (the “First Amendment”) is made and entered into as of the 25th day of June 2020 (the “Effective Date”). by and between Rapid Therapeutic Science Laboratories, Inc., a Nevada for profit company, on behalf of its assignor, Texas MDI, Inc. a Texas for-profit corporation (the “Manufacturer”) and EM3 Methodologies, LLC, an Arizona limited liability company, and Richard Adams, individually a resident of Arizona, (collectively the “Company”). Company and Manufacturer may be collectively referred to herein as the “Parties,” and individually as a “Party.”